Optimal combination of gemcitabine, sorafenib, and S-1 shows increased efficacy in treating cholangiocarcinoma in vitro and in vivo
发布时间:2025-11-17
发表刊物:Anti-Cancer Drugs
ISSN号:0959-4973
是否译文:否
发表时间:2016-08-01
论文类型:期刊论文
